vs
Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
ESCO TECHNOLOGIES INC is the larger business by last-quarter revenue ($289.7M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs -82.0%, a 91.9% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs -22.7%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $-36.6M). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs -11.5%).
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
ESE vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $289.7M | $164.7M |
| Net Profit | $28.7M | $-135.0M |
| Gross Margin | 41.4% | — |
| Operating Margin | 13.2% | -43.3% |
| Net Margin | 9.9% | -82.0% |
| Revenue YoY | 17.3% | -22.7% |
| Net Profit YoY | 22.2% | -104.8% |
| EPS (diluted) | $1.11 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $289.7M | $164.7M | ||
| Q3 25 | $286.5M | $211.0M | ||
| Q2 25 | $296.3M | $178.9M | ||
| Q1 25 | $265.5M | $1.2B | ||
| Q4 24 | $247.0M | $213.2M | ||
| Q3 24 | $298.5M | $196.8M | ||
| Q2 24 | $260.8M | $186.7M | ||
| Q1 24 | $249.1M | $210.1M |
| Q4 25 | $28.7M | $-135.0M | ||
| Q3 25 | $218.7M | $15.9M | ||
| Q2 25 | $26.1M | $-64.8M | ||
| Q1 25 | $31.0M | $866.6M | ||
| Q4 24 | $23.5M | $-65.9M | ||
| Q3 24 | $34.3M | $-106.7M | ||
| Q2 24 | $29.2M | $-99.2M | ||
| Q1 24 | $23.2M | $-91.6M |
| Q4 25 | 41.4% | — | ||
| Q3 25 | 45.9% | — | ||
| Q2 25 | 41.2% | — | ||
| Q1 25 | 41.1% | — | ||
| Q4 24 | 39.8% | — | ||
| Q3 24 | 40.1% | — | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | 38.8% | — |
| Q4 25 | 13.2% | -43.3% | ||
| Q3 25 | 17.2% | 1.4% | ||
| Q2 25 | 11.2% | -19.5% | ||
| Q1 25 | 15.3% | 82.5% | ||
| Q4 24 | 11.4% | -76.2% | ||
| Q3 24 | 14.8% | -27.7% | ||
| Q2 24 | 14.3% | -21.5% | ||
| Q1 24 | 11.7% | -21.6% |
| Q4 25 | 9.9% | -82.0% | ||
| Q3 25 | 76.3% | 7.5% | ||
| Q2 25 | 8.8% | -36.3% | ||
| Q1 25 | 11.7% | 73.7% | ||
| Q4 24 | 9.5% | -30.9% | ||
| Q3 24 | 11.5% | -54.2% | ||
| Q2 24 | 11.2% | -53.1% | ||
| Q1 24 | 9.3% | -43.6% |
| Q4 25 | $1.11 | $-1.63 | ||
| Q3 25 | $8.43 | $0.20 | ||
| Q2 25 | $1.01 | $-0.83 | ||
| Q1 25 | $1.20 | $10.04 | ||
| Q4 24 | $0.91 | $-0.85 | ||
| Q3 24 | $1.32 | $-1.39 | ||
| Q2 24 | $1.13 | $-1.29 | ||
| Q1 24 | $0.90 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $1.9B |
| Total DebtLower is stronger | $145.5M | — |
| Stockholders' EquityBook value | $1.6B | $-205.3M |
| Total Assets | $2.4B | $2.9B |
| Debt / EquityLower = less leverage | 0.09× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $1.9B | ||
| Q3 25 | $101.3M | $1.7B | ||
| Q2 25 | $78.7M | $2.0B | ||
| Q1 25 | $57.4M | $2.0B | ||
| Q4 24 | $71.3M | $1.1B | ||
| Q3 24 | $66.0M | $1.0B | ||
| Q2 24 | $63.0M | $1.1B | ||
| Q1 24 | $59.4M | $884.8M |
| Q4 25 | $145.5M | — | ||
| Q3 25 | $186.0M | — | ||
| Q2 25 | $525.0M | — | ||
| Q1 25 | $88.0M | — | ||
| Q4 24 | $112.0M | — | ||
| Q3 24 | $122.0M | — | ||
| Q2 24 | $173.0M | — | ||
| Q1 24 | $191.0M | — |
| Q4 25 | $1.6B | $-205.3M | ||
| Q3 25 | $1.5B | $-155.8M | ||
| Q2 25 | $1.3B | $-206.5M | ||
| Q1 25 | $1.3B | $-185.8M | ||
| Q4 24 | $1.2B | $-1.1B | ||
| Q3 24 | $1.2B | $-1.1B | ||
| Q2 24 | $1.2B | $-980.2M | ||
| Q1 24 | $1.2B | $-893.9M |
| Q4 25 | $2.4B | $2.9B | ||
| Q3 25 | $2.4B | $2.6B | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $1.8B | $2.7B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.8B | $1.8B | ||
| Q2 24 | $1.8B | $1.9B | ||
| Q1 24 | $1.8B | $1.8B |
| Q4 25 | 0.09× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.09× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.9M | $-34.3M |
| Free Cash FlowOCF − Capex | $63.0M | $-36.6M |
| FCF MarginFCF / Revenue | 21.7% | -22.3% |
| Capex IntensityCapex / Revenue | 2.0% | 1.4% |
| Cash ConversionOCF / Net Profit | 2.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | $239.6M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.9M | $-34.3M | ||
| Q3 25 | $109.9M | $-66.3M | ||
| Q2 25 | $73.7M | $-58.3M | ||
| Q1 25 | $24.1M | $870.1M | ||
| Q4 24 | $34.2M | $-30.0M | ||
| Q3 24 | $72.1M | $-77.0M | ||
| Q2 24 | $36.2M | $-71.5M | ||
| Q1 24 | $10.5M | $70.8M |
| Q4 25 | $63.0M | $-36.6M | ||
| Q3 25 | $97.8M | $-69.7M | ||
| Q2 25 | $64.9M | $-59.6M | ||
| Q1 25 | $14.0M | $868.4M | ||
| Q4 24 | $29.0M | $-33.8M | ||
| Q3 24 | $60.9M | $-77.5M | ||
| Q2 24 | $27.6M | $-78.8M | ||
| Q1 24 | $2.0M | $61.2M |
| Q4 25 | 21.7% | -22.3% | ||
| Q3 25 | 34.1% | -33.1% | ||
| Q2 25 | 21.9% | -33.3% | ||
| Q1 25 | 5.3% | 73.8% | ||
| Q4 24 | 11.7% | -15.8% | ||
| Q3 24 | 20.4% | -39.4% | ||
| Q2 24 | 10.6% | -42.2% | ||
| Q1 24 | 0.8% | 29.1% |
| Q4 25 | 2.0% | 1.4% | ||
| Q3 25 | 4.2% | 1.6% | ||
| Q2 25 | 3.0% | 0.7% | ||
| Q1 25 | 3.8% | 0.1% | ||
| Q4 24 | 2.1% | 1.8% | ||
| Q3 24 | 3.8% | 0.3% | ||
| Q2 24 | 3.3% | 4.0% | ||
| Q1 24 | 3.4% | 4.6% |
| Q4 25 | 2.40× | — | ||
| Q3 25 | 0.50× | -4.17× | ||
| Q2 25 | 2.83× | — | ||
| Q1 25 | 0.78× | 1.00× | ||
| Q4 24 | 1.46× | — | ||
| Q3 24 | 2.10× | — | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
PTCT
Segment breakdown not available.
